An unusual case of campylobacter pouchitis resembling the endoscopic appearance of Crohn's disease is reported.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983316 | PMC |
| http://dx.doi.org/10.1155/2016/5254914 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Value of routine stool testing for pathogenic bacteria in the evaluation of symptomatic patients with ileal pouches.
Gastroenterol Rep (Oxf)
May 2018
Department of Gastroenterology & Hepatology, Digestive Disease and Surgery Institute, The Cleveland Clinic Foundation, Cleveland, OH, USA.
Background: In symptomatic patients with an ileal pouch, stool studies are often sent to diagnose enteric pathogens. Aim of this study is to find the value of routine stool studies in the evaluation of symptomatic patients and the clinical implications of such pathogens in patients with ileal pouches.
Methods: Consecutive ileal pouch-anal anastomosis (IPAA) patients who had stool tests out of a 2283-case registry from 2002 to 2015 were included in the study.
Campylobacter Pouchitis Mimicking the Appearance of Crohn's Disease.
Case Rep Gastrointest Med
August 2016
Department of Medicine, Division of Gastroenterology, Northwestern University, Chicago, IL 60611, USA.
An unusual case of campylobacter pouchitis resembling the endoscopic appearance of Crohn's disease is reported.
View Article and Find Full Text PDFRifaximin: a nonabsorbed oral antibiotic.
Rev Gastroenterol Disord
March 2005
College of Pharmacy, Washington State University, Spokane, Washington, USA.
Rifaximin is a rifamycin analogue with a broad spectrum of activity similar to that of rifampin; however, because it is poorly absorbed in the gastrointestinal tract, the focus of its development has been on intestinal infections and diseases. This agent has proven to be as effective as ciprofloxacin in treating travelers' diarrhea due to Escherichia coli, although it is ineffective in treating infections due to Campylobacter jejuni. Other potential uses for rifaximin in gastroenterologic disorders include treatment of hepatic encephalopathy, intestinal gas and gas-related symptoms, diverticular disease, intestinal bacterial overgrowth, pouchitis, ulcerative colitis, and active Crohn's disease.
View Article and Find Full Text PDFCrohn's disease, ulcerative colitis or indeterminate colitis--how important is it to differentiate?
Acta Gastroenterol Belg
August 2001
Department of Pathology, University Hospital Leuven, Belgium.
In most patients coming to the general practitioner or specialist with a history of bloody diarrhoea, bacteria or drugs are the most likely causative agents and it will be possible to make a diagnosis fairly easily. Because of differences in treatment, ulcerative colitis (UC) and Crohn's disease (CD) must however seriously be considered especially in younger patients, with severe symptoms and whenever the history is prolonged. A variety of colitides may indeed be clinically confused with UC and CD.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!